SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-706932
Filing Date
2016-09-12
Accepted
2016-09-12 07:32:56
Documents
7
Period of Report
2016-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256641d8k.htm 8-K 37824
2 EXHIBIT 2.1 d256641dex21.htm EX-2.1 507643
3 EXHIBIT 3.1 d256641dex31.htm EX-3.1 145118
4 EXHIBIT 10.1 d256641dex101.htm EX-10.1 56839
5 EXHIBIT 99.1 d256641dex991.htm EX-99.1 32825
6 GRAPHIC g256641oshensnap7.jpg GRAPHIC 7847
7 GRAPHIC g256641snap8.jpg GRAPHIC 8020
  Complete submission text file 0001193125-16-706932.txt   804137
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 161880021
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences